Named entity (NE) recognition is a fundamental task in biological relationship mining. This paper considers protein/gene collocates extracted from biological corpora as restrictions to enhance the precision rate of protein/gene name recognition. In addition, we integrate the results of multiple NE recognizers to improve the recall rates. Yapex and KeX, and ABGene and Idgene are taken as examples of protein and gene name recognizers, respectively. The precision of Yapex increases from 70.90 to 85.84% at the low expense of the recall rate (i.e., it only decreases 2.44%) when collocates are incorporated. When both filtering and integration strategies are employed together, the Yapex-based integration with KeX shows good performance, i.e., the F-score increases by 7.83% compared to the pure Yapex method. The results of gene recognition show the same tendency. The ABGene-based integration with Idgene shows a 10.18% F-score increase compared to the pure ABGene method. These successful methodologies can be easily extended to other name finders in biological documents.
Introduction
Named entities are basic constituents in a document and recognizing them is a fundamental step for document understanding. In the message understanding competition MUC [1] , named entity extraction was one of the evaluation tasks. The named entities included organizations, people, locations, date/time expressions, monetary expressions, and percentage expressions. Several approaches have been proposed to capture these types of terms. For example, corpus-based methods are employed to extract Chinese personal names, and rulebased methods are used to extract Chinese date/time expressions as well as monetary and percentage expressions [2, 3] . The corpus-based approach is adopted because a large personal name database is available for training. In contrast, rules that have good coverage exist for date/time expressions, so that the rule-based approach is adopted.
In the past, named entity extraction has mainly focused on general domains. However, many scientific documents have been published recently, especially in the biomedical domain. Several attempts have been made to mine knowledge from biomedical documents [4] , such as identifying protein/gene names, recognizing protein interactions, and capturing specific relations in databases. One of the goals is to construct a knowledge base automatically and find new information embedded in documents [5] . Craven and Kumlien [5] identified that the information extraction task may include sub-cellular/cell localization of proteins, tissue localization of proteins, and drug interactions with a given protein. names, gene names, drug names, disease names, and so on, have also been recognized [6] [7] [8] [9] [10] [11] [12] [13] [14] . Some of them have used machine learning methods, e.g., Hidden Markov Models (HMMs), and Support Vector Machines (SVMs), to recognize protein/gene names [6, 8, 10, [12] [13] [14] . Others have used knowledge-based rules, accompanied by lexical or morphological analysis, to help with protein/gene name detection [7, 9, 11] . The relationships between these entities, e.g., protein-protein, gene-gene, drug-gene, drug-disease, etc., have also been extracted [12, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . EDGAR [12] used a POS tagger, NLP techniques, other knowledge sources, and contextual rules to identify the relationships between genes and drugs in cancer therapy. Meanwhile, Adamic et al. [15] used a statistical method to identify gene-disease connections from literature. Protein/gene interactions have been discovered automatically in the literature by methods that utilized natural language processing, parsing techniques or the analysis of sentences that discussed interactions by using frequency analysis of individual words [16, 17, [20] [21] [22] [23] 25] . Other relationships were extracted to improve the performance of named entity recognition, e.g., through the information supplied from protein/ gene keywords [18, 19] or the Naïve Bayes classifier [24] .
Named entity recognition is a fundamental step for mining knowledge from biological articles. After identifying named entities, most research [16, [21] [22] [23] 26] has been based on some special verbs and their related noun forms to discover molecular pathways or relationships. These pre-specified words indicate actions associated with protein or gene interactions. Blaschke et al. [16] used 14 keywords for protein-protein interactions from MEDLINE articles. Ng et al. [21] applied some function words for the inhibit-activate relationships. Sekimizu et al. [26] extracted gene relations associated with seven frequently used verbs found in MEDLINE abstracts. In all these papers, with the exception of Sekimizu, the keywords are listed by intuition. Some keywords are common to most of the papers, while some are special. The problem with the above approaches is that we cannot be sure if the keyword set is complete for mining biological relationships. This motivated us to find biological keywords in an automatic way.
Collocation denotes two or more words that have strong relationships [27] . For example, if the phrase ''NF-kappa B activation'' often appears in a sentence where ''NF-kappa B'' is a protein name, it means that ''NF-kappa B'' and ''activation'' are collocations, i.e., ''NF-kappa B'' and ''activation'' occur together in the document. The related technologies have been applied to terminological extraction, natural language generation, parsing, and so on. This paper deals with two special collocations in the biological domain-namely: protein collocation and gene collocation. We will determine those keywords that co-occur with protein or gene names by using statistical methods. Such terms, referred to as collocates of proteins or genes hereafter, will be considered as restrictions in protein/gene name extraction. In the former example of ''NF-kappa B activation,'' ''activation'' is the collocate of the protein ''NF-kappa B.'' Improving the precision rate, without substantially lowering the recall rate is the primary goal of this approach. Furthermore, how to improve the recall rate at a small expense to the precision rate is another interesting topic. We will explore this issue by introducing an integration of multiple name recognizers. In summary, the motivation of this paper is to increase the performance of existing molecular name detectors. The methods we adopted will be explained in Sections 3-5.
The rest of this paper is organized as follows. The protein and the gene name recognizers used in this study are introduced in Section 2. The collocation method we adopted is described in Section 3. The filtering and the integration strategies are proposed in Sections 4 and 5, respectively and the experimental results of these two strategies are shown and discussed. Finally, in Section 6, we present our conclusions and suggest the direction of future research.
Molecular name recognizers
The detection of molecular names such as proteins and genes presents a challenging task due to their variant structural characteristics, their resemblance to regular noun phrases and their similarity to other kinds of biological substances. Many irregularities and ambiguities exist in gene and protein nomenclature. For example, protein/ gene names may be synonymous with common words, such as ''ran,'' ''envelope,'' ''cat,'' etc. In addition, some principles of the nomenclature are similar to chemicals, e.g., ''Ca2+-ATPase'' is a protein while ''Ca2+'' is a chemical. Consequently, several issues have to be addressed during protein/gene name recognition.
Previous approaches to biological named entity extraction can be classified in two types-namely: rulebased [7, 11, 13, 28, 29] and corpus-based [6] . KeX developed by Fukuda et al. [7] and Yapex developed by Olsson et al. [11] were based on handcrafted rules for extracting protein names. Kex used surface clues like upper case letters, numerical letters, and symbols to extract core terms and later connected them to other terms in the surrounding text [7] . Yapex first implemented some heuristic steps described by Fukuda et al. [7] , and then applied filters and knowledge bases to remove false hits. Finally, Yapex utilized the syntactic information from the parser to identify protein names.
ABGene developed by Tanabe et al. [13] used BrillÕs tagger [30] as the fundamental extraction program, followed by additional layers of post-processing rules to filter out false positives, as well as to recover false negatives in the first-step tagging of gene and protein names. BrillÕs tagger assigns part-of-speech tags to words. For example, for the title ''Genetic characterization in two Chinese women,'' BrillÕs tagger will produce the tagged result ''Genetic/JJ characterization/NN in/IN two/CD Chinese/JJ women/NNS'' to indicate ''Genetic'' as an adjective, ''characterization'' as a common noun, ''in'' as a preposition, ''two'' as a cardinal number, ''Chinese'' as an adjective and ''women'' as a plural common noun. Since gene names are usually single nouns or noun phrases, it is helpful to recognize gene names by applying BrillÕs tagger. After tagging, the post-processing rules are used to filter out false positives and recover false negatives. For filtering false positives, on the one hand, ABGene precompiles some general biological terms (acids, antigen, etc.,), amino acid names, restriction enzymes, cell lines, and organism names. On the other hand, ABGene uses regular expressions to indicate that a word is not a gene name, e.g., common drug suffixes (-ole, -ane, -ate, etc.). For recovering false negatives, ABGene applies contextual rules to find compound names. For example, one rule is ''ANY-GENE CC x,'' where ''ANYGENE'' is a tagged gene, ''CC'' is a coordinating conjunction and ''x'' is the current word. The constraint of this rule is that ''x'' contains a capital letter, dash or number, and is not a verb or an adverb. If matched, the tag of ''x'' will be changed to CONTEXTGENE. Finally, compound names are found. Some examples of filtering out false positives and recovering false negatives are described in [13] . Idgene developed by Fan [29] is a dictionarybased gene name identification program. The basic idea of Idgene is to use exact match for gene symbols and fuzzy match for gene names/phenotypes, which gives a suggestion list of the hit genes weighted by surrounding contexts. Idgene also uses BrillÕs tagger to get POS tags, and then computes the scores of the exact/fuzzy matches. Finally, Idgene merges shorter terms with longer terms to obtain the final scores. Both ABGene and Idgene utilize some hand-made rules for extracting gene names. Collier et al. [6] adopted a machine learning approach that involved training a Hidden Markov Model with a small corpus of 100 MEDLINE abstracts to extract the names of gene and gene products.
Different taggers have their own specific features. Idgene was evaluated on 156 Chinese Gene Variation papers selected from 1997 to 1998 BIOSIS Previews and EMBASE [31] . It had a 24.68% precision rate and an 85.39% recall rate. ABGene was developed as a general-purpose gene tagger. Fan [29] 
Statistical methods for collocation
The overall flow of our method is shown in Fig. 1 . To extract protein/gene collocates, we need a corpus in which protein/gene names have been tagged. Preparing a tagged biological corpus is the first step, after which common stopwords are removed and stemming (e.g., map ''listed'' and ''listing'' to its root form ''list'') is applied to gather and group more informative words. The collocation values of the proteins/genes and surrounding words are then calculated. Finally, these values are employed to determine which neighbouring words are the desired collocates. The major modules are specified in detail in the following subsections.
Step 1: Tagging the corpus
To calculate the collocation values of words with proteins/genes from a corpus, it is first necessary to recognize protein/gene names. Nevertheless, the goal of this paper deals with the performance issue of protein/ gene name tagging. Hence, preparing a protein/gene name tagged corpus and developing high performance protein/gene name taggers seem to be a chicken-andegg problem. Because the corpus developed in the first step is used to extract the contextual information of proteins/genes, a completely tagged corpus is not necessary at the first step. A dictionary-based approach for molecular name tagging, i.e., full pattern matching between the dictionary entries and the words in the corpus, is simple. The major problem is its coverage. Those protein/gene names that are not listed in the dictionary, but appear in the corpus will not be recognized. Thus, this approach only produces a partially tagged corpus, which is sufficient to acquire contextual information for use later in this research.
3.2.
Step 2: Preprocessing
Step 2.1: Exclusion of stopwords
Stopwords are common English words (such as the preposition ''in'' and the article ''the'') that frequently appear in the text, but are not helpful in discriminating special classes. Because they are distributed throughout the corpus, they should be filtered out to remove their unnecessary impact in the text. The stopword list in this study was collected with reference to the stoplists of Fox [33] , but words that also appeared in the protein/gene lexicon have been removed from the stoplist. For example, ''of'' is a constituent of the gene name ''translocase of inner mitochondrial membrane 8 homolog A,'' so ''of'' is excluded from the stoplist. The major reason for excluding such stopwords from the Fox list is to enable exact pattern matching with protein/gene names. Finally, 387 stopwords were used.
Step 2.2: Stemming
Stemming is the procedure of transforming a word from an inflected form to its root form. For example, ''suggested'' and ''suggestion'' will be mapped into the root form ''suggest'' after stemming. The procedure can group the words with the same semantics and therefore reflect more information around the proteins/genes.
Step 3: Computing collocation statistics
Pearson [34] has discussed problems of gene nomenclature in detail. The irregularity and the ambiguities in gene and protein nomenclature make name identification more difficult. From one MEDLINE abstract, we have the following title: ''The relationship between Ca2+-ATPase and freely exchangeable Ca2+ in the dense tubules: a study in platelets from women.'' In this example ''Ca2+-ATPase'' is a protein, while ''Ca2+'' is a chemical. However, they are both composed of letters plus numbers and symbols. Obviously, the nomenclature rules are irregular, so we must find other clues to help name recognition. The clues here are in the context. For ''Ca2+-ATPase,'' the context is ''The relationship between'' and ''and freely exchangeable Ca2+ in'' if we take the three words before, and the five words after it. For ''Ca2+,'' its context is ''between Ca2+-ATPase and freely exchangeable'' and ''in the dense tubules: a.'' If we know the protein collocates contain ''relationship,'' we can pick ''Ca2+-ATPase'' as a protein and discard ''Ca2+.'' In such a way, a collocate of protein/gene can help to improve precision. This section proposes three collocation statistics to find the collocates of proteins/genes, which often co-occur with protein/gene names in the corpora.
Frequency
The first statistical method we used in this study was frequency. In this phase, the collocates were selected by frequency. To gather more flexible relationships, we defined a collocation window that has five words on each side of protein/gene names. Then, collocation bigrams at a distance were captured. In general, more occurrences in the collocation windows are preferred, but the standard criteria for frequencies are not acknowledged. For example, ''go'' occurs in the protein collocation window 14 times, and ''pathway'' occurs in the gene collocation windows nine times. How to decide if ''go'' is a good protein collocate, while ''pathway'' is not a good gene collocate is a difficult issue. Hence, other collocation models are also considered.
Mean and variance
The second statistical method we applied was mean and variance. The mean value of collocations can indicate how far collocates are typically located from protein/gene names. Furthermore, this method shows the deviation from the mean. The standard deviation of value zero indicates that the collocates and the protein/ gene names always occur at exactly the same distance equal to the mean value. If the standard deviation is low, two words usually occur at about the same distance, i.e., near the mean value. If the standard deviation is high, then the collocates and the protein/gene names usually occur at random distances.
We used the following formulas to calculate mean and standard deviations, respectively.
where d i is the average distance for word i in the collocation windows. d ij is the distance of the jth occurrence of word i away from proteins/genes in the collocation windows. For example, d ij = À1 means the jth occurrence of word i is located directly to the left of the proteins/genes in the collocation window. n_count i is the total number of occurrences of word i in the document set. s i is the standard deviation of d ij .
The following examples illustrate the meaning of mean and variance for the word ''activation'' and proteins.
(1) IL-2 gene expression and <prot>NF-kappa B </prot> activation through <prot>CD28</prot> requires rea ctive oxygen production by <prot>5-lipoxygenase </prot>.
(2) Activation of the <prot>CD28 surface receptor </prot> provides a major costimulatory signal for T cell activation.
In Sentence (1), activation occurs directly on the right of NF-kappa B and on the left 2nd position away from CD28. In Sentence (2), ''activation'' occurs on the left 3rd position away from CD28 surface receptor. Thus, the average distance for activation is (1 + (À2) + (À3))/ 3. The result is À1.33, and the standard deviation is ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ð1 À ðÀ1:
The value of the standard deviation is equal to 1.472 which means that activation may occur on the left or right at a distance of 1.472 words away from the average distance, which is À1.33 in this example.
t test model
When the values of mean and variance are computed, it is necessary to know that two words do not co-occur by chance. We also need to know if the standard deviation is low enough. In other words, we have to set a threshold in the above approach. To achieve the statistical confidence that two words have a collocation relationship, a hypothesis testing, t test, is adopted.
Consider a document set with total n words. The t value for each word i, t i , is formulated as follows:
where N is the total word frequencies in the window,
, and p protein/gene is the probability of protein/gene.
The confidence level, i.e., a, is a statistical calculation that measures the degree of certainty (or likelihood) of a correlation, result or forecast. When a is equal to 0.005, the value of t is 2.576. In the t test model, if the t value is larger than 2.576, the word is regarded as a good collocate of a protein/gene with 99.5% confidence.
Step 4: Extraction of collocates
MEDLINE is a massive biomedical corpus for information retrieval, information extraction and knowledge discovery. Biomedical experts often explore new developments in special topics by retrieving relevant documents from MEDLINE. To preserve the independence between proteins and genes, we used different document sets as training corpora for proteins and genes in this extraction phase.
In the experiments for proteins, the documents used in TREC 2003 Genome Track [35] were considered as the training corpus. The text collection consists of 525,936 MEDLINE abstracts where indexing was completed between 4/1/2002 and 4/1/2003. We applied the procedures Steps 1-3 mentioned in this section to this data collection. There are 57,307 protein collocations generated in Step 3. The collocates are not filtered out by part of speech, so the output may contain nouns, prepositions, numbers, verbs, etc.
In the experiments for genes, the documents gathered from the LocusLink database [36] (http://www.ncbi.nlm. nih.gov/LocusLink) were adopted as the training corpus. The text collection consists of 30,936 MEDLINE abstracts. Applying Steps 1-3 in Section 3 to this document collection, we obtained 14,150 gene collocations.
The collocates extracted from a corpus not only serve as conditions of protein or gene names, but also facilitate the discovery of the relationship between proteins (genes) [18] . Verbs are the major targets in the extraction of biological information, (such as Blaschke et al. [16] , Ng et al. [21] , and Ono et al. [37] , etc.). This is because the subjects and the objects related to these verbs tend to be names of proteins or genes. To ensure that the collocates selected in Step 3 were verbs, we assigned part of speech to these words. There are 12,826 protein collocates and 3,541 gene collocates. Examples of protein and gene collocates are listed in Tables 1 and 2 . 
Filtering strategies
For protein/gene name recognition, rule-based systems and dictionary-based systems are usually complementary. Rule-based systems can recognize those protein/gene names not listed in a dictionary, but some false entities may also pass at the same time. For example, both ''HCMV'' and ''NFAT'' are composed of capital letters. However, ''HCMV'' is a virus that may be recognized as protein/gene, whereas ''NFAT'' is definitely a protein. Other examples are ''BL-2,'' a cell line which may be tagged as a protein/gene name, and ''AP-2,'' which is a protein. Dictionary-based systems can recognize molecular entities in a dictionary, but the coverage of all proteins/genes is a major deficiency. A challenge is how to use dictionary information to correctly identify molecular entities. In this section, we employ collocates of proteins/genes mined earlier to help identify the molecular entities. The Yapex system [11] and ABGene [13] are adopted to propose candidates, and protein/gene collocates serve as restrictions to filter out less likely protein/gene names.
The following filtering strategies are proposed. We explain them from a protein viewpoint. Let us assume that the candidate set M0 is the output generated by Yapex.
M1: For each candidate in M0, we will check if a collocate is found in its collocation window. If it is, we will tag the candidate as a protein name. Otherwise, we will discard it. For example, in the sentence IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase., Yapex tagged ''IL-2,'' ''CD28,'' and ''5-lipoxygenase'' as proteins. If ''activation'' and ''reactive'' are protein collocates, then ''CD28'' and ''5-lipoxygenase'' will be retained, since ''activation'' and ''reactive'' occur in the collocation window of ''CD28'' and ''reactive'' occurs in the collocation window of ''5-lipoxygenase.'' M2: Some of the collocates may be substrings of protein names. We relax the restriction in M1 as follows: If a collocate appears in the candidate, or in the collocation window of the candidate, then we tag the candidate as a protein name; otherwise, we discard it. For example, in the sentence: . . ., since FGF-1 -induced Rel/ kappa B binding proteins do not contain significant levels of c-Rel and are not identical with the CD28 response complex, ''FGF-1'' and ''Rel/kappa B binding proteins'' are protein names. ''FGF-1'' can be retained with strategy M1, while ''Rel/kappa B binding proteins'' cannot because the protein collocate ''binding'' is located in the window of ''FGF-1'' and not in the window of ''Rel/kappa B binding proteins.'' If we apply strategy M2, the latter will be found.
M3: Some protein names may appear more than once in a document. They may not always co-occur with some collocates in each occurrence. In other words, the protein candidate and some collocates may co-occur in the first, the second, or even the last occurrence. To resolve this problem, we revise M1 and M2 as follows. If there exists a collocate co-occurring with a protein candidate during checking, the candidate without any collocate is kept undecided instead of being discarded. After all the protein names have been examined, those undecided candidates may be considered as protein names if one of their co-occurrences contains any collocate. In other words, as long as a candidate has been confirmed once, it is assumed to be a protein throughout. In this way, there are two filtering alternatives M31 and M32 from M1 and M2, respectively. For example, in the sentence: ''Full activation of the MAP kinases that phosphorylate the Jun activation domain, JNK1 and JNK2, required costimulation of T cells with either TPA and Ca2+ ionophore or antibodies to TCR and CD28,'' there are no protein collocates around ''CD28.'' If we apply strategy M31, ''CD28'' will be retained as a protein because it has been collocated with protein collocates from other parts of the documents. The example for strategy M32 is the same with the one illustrated for strategy M31. Although there are no protein collocates around proteins ''the Jun activation domain'' and ''CD28,'' strategy M32 helps recognize them as follows. First, ''the Jun activation domain'' will be detected because a collocate ''activation'' appears in the protein name ''the Jun activation domain''. Furthermore, ''CD28'' will be retained as a protein because it has been collocated with protein collocates from other parts of the documents.
Evaluation of filtering strategies
To get an additional objective evaluation, we utilized another corpus of 101 abstracts used by Yapex [http:// www.sics.se/humle/projects/prothalt] for protein extraction. Similarly, we used the GENIA corpus version 3.02 [38] of 2000 abstracts for the gene evaluations. Using the test corpora and answer keys provided in the Yapex project and the GENIA project, the evaluation results of filtering strategies for proteins and genes are listed in Tables 3 and 4 , respectively. Note that the baseline model M0 was not applied during the filtering strategies.
We can partition the labelled results into four groups:
True Positives (TP): items correctly labelled as positive; False Positives (FP): items incorrectly labelled as positive; True Negatives (TN): items correctly labelled as negative; False Negatives (FN): items incorrectly labelled as negatives.
In Table 3 , precision, recall, and F-score are calculated according to the following equations:
Recall ðRÞ ¼ TP TP þ FN ; and
Compared with the baseline model M0 in Table 3 , the precision rates of all the four models using protein collocates improved more than 11.20%. The recall rates of M1 and M2 decreased 12.11 and 11.57%, respectively. Thus, the overall F-scores of M1 and M2 decreased 0.46 and 0.06%, compared to M0. In contrast, if the decision of tagging was deferred until all the information was considered, the recall rates only decreased by 3.05 and 2.44%, and the F-scores of M31 and M32 increased 5.97 and 6.25% relative to M0. The best strategy, M32, improved the precision rate from 70.90 to 85.84%, and the F-score from 70.22 to 76.47%.
In Table 4 , the precision rates of all the four models using gene collocates were improved more than 10.06%. The recall rates of M1 and M2 decreased 5.06 and 4.67%, respectively. Thus, the overall F-scores of M1 and M2 increased 2.50 and 4.36%, compared to M0. If the decision of tagging was deferred until all the information was considered, the recall rates only decreased by 3.10 and 2.67%, and the F-scores of M31 and M32 increased by 5.41 and 5.77% relative to M0. The best one, M32, improved the precision rate from 55.87 to 70.08%, and the F-score from 65.22 to 70.99%. Compared to the experimental results shown in Table 3 , the same trends occurred for genes shown in Table 4 . The results meet our expectations, i.e., to enhance the precision rate, without significantly reducing the recall rate.
Consideration of the recall rate

Integration strategies
Here, we analyze the tagged results from protein/gene taggers. There are four types of errors generated by the taggers.
(1) Type 1: completely wrong labelling, e.g., ''HCMV'' may be tagged as a protein. (2) Using the filtering strategies introduced in Section 4.1, the most helpful collocates were of Type 1. For Types 2 and 3, the collocates help a little because they may also appear in the collocation window of the wrong labelled gene/protein names. To solve the errors of Types 2 and 3, there is an additional requirement to determine where the name begins and ends within a sentence. Finally, our filtering method cannot help with Type 4, since we cannot produce untagged names.
To improve recall, we introduce integration strategies based on a hybrid concept of two protein/gene name taggers. By employing the integration strategies, we resolve errors of Types 2 and 3 by employing integration strategies. The basic idea is that different protein/gene name taggers have their own specific features such that they can recognize different sets of NEs according to their rules or recognition methods. Among the proposed protein/ gene names provided by different systems, there may exist some overlaps and some differences. In other words, a protein/gene name recognizer may tag a protein or gene that another recognizer cannot identify, or both of them may accept certain common molecular entities. The integration strategies are used to select correct protein/gene names proposed by multiple recognizers. In this study, we conducted several experiments for different domains: (1) For protein name recognition, Yapex and KeX are adopted because they are freely available on the web; (2) For gene name recognition, ABGene and Idgene are included because the developers were kind enough to provide the resources for our experiments.
Because protein/gene candidates are proposed by two named entity extractors independently, they may be completely separate, completely the same, overlapped in between, overlapped in the beginning, or overlapped at the end. Fig. 2 shows these five cases. For example, if there is a sentence as follows:
We have previously found a high expression of human Ah receptor (TCDD receptor) mRNA in peripheral blood cells of individuals.
If one system only tagged Ah receptor as a protein name and the other system proposed TCDD receptor as a protein name, then this sentence belongs to Type A: completely separate. If two systems all tagged TCDD receptor as a protein name, this is a case of Type B: completely the same. If one system tagged human Ah receptor as a protein name, while another tagged Ah receptor (TCDD receptor) as a protein name, this is a case of Type C: overlapped in between, where Ah receptor is the overlapped part. If one system tagged Ah receptor as a protein name and the other one proposed Ah receptor (TCDD receptor) as a protein name, this is a case of Type D: overlapped in the beginning where Ah receptor is the overlapped part.
For the last case: Type E, let us look at another example:
Whereas different anti-CD4 mAb or HIV-1 gp120 could all trigger activation of the protein tyrosine kinases p56lck and p59fyn and phosphorylation of the Shc adaptor protein, which mediates signals to Ras, they differed significantly in their ability to activate NF-AT.
If one system recognized protein tyrosine kinases p56lck as a protein name and the others recognized p56lck as a protein name, we called this a Type E and p56lck the overlapped part.
The integration strategies shown as follows combine the results from two molecular named entity extractors.
When the protein/gene names produced by two recognizers are completely separate (i.e., type A), we retain each of them as the protein/gene candidates. This integration strategy postulates that one protein (or gene) name recognizer may extract some proteins (or genes) that another recognizer cannot identify. When the protein/gene names proposed by two recognizers are exactly the same (i.e., type B), we also retain each of them as the protein/gene candidates. The reason is that when both taggers accept the same protein (or gene) names, there must be some special features that the protein (or gene) names fit. When the protein/gene names tagged by two taggers have partial overlap (i.e., types C, D, and E), two additional integration strategies are employed, i.e., Yapex-based and KeX-based strategies for proteins, and AB-based and Id-based strategies for genes. In the former strategy, we adopt protein/gene names tagged by Yapex/ABGene as candidates and discard the ones produced by KeX/Idgene. In contrast, the names tagged by KeX/Idgene are kept in the latter strategy. The integration strategy is used because each recognizer has its own characteristics, and we do not know, in advance, which one will perform better. Therefore, we consider one of them as a basis, and then introduce new contributions from another recognizer. That is, if KeX serves as a basis, we choose the tagged names by KeX if any overlaps exist between KeX and Yapex.
Integration evaluation of proteins
The integration strategies described in Section 5.1 bring together all the possible protein/gene candidates except the ambiguous cases (i.e., types C, D, and E). That tends to increase the recall rate. To avoid reducing the precision rate, we also employed the protein/ gene collocates mentioned in Section 3 to filter out the less likely protein/gene candidates. Furthermore, to objectively evaluate the performance of the proposed collocates, we applied our strategies to the test corpus using the terms suggested by human experts on protein evaluation. A total of 48 verbal protein keywords that were used to find the pathway of proteins are listed in Appendix.
The following four sets of experiments were designed for the Yapex-and KeX-based integration strategies. The experimental results for Yapex-based and KeXbased integration are listed in Tables 5 and 6 , respectively. M0 is the baseline model. The named entities proposed by M0 are combined from the results of Yapex and KeX without filtering (i.e., without collocate checking). M0 is used to evaluate the performance changes of the following four cases: without filtering, filtering only, integration only; and both filtering and integration.
The tendencies M32 > M31 > M2 > M1 are still kept in the new experiments. The strategy of delaying the decision until clear evidence found is workable. The performances of YA, YA-C, KA, and KA-C are better than the performances of the corresponding models (i.e., YB, YB-C, KB, and KB-C). This shows that the set of collocates proposed by our system is more complete than the set of terms suggested by human experts. Compared with the recall rate of M0 in Table 3 (i.e., 69.53%), the recall rates of both Yapex-and KeX-based integration are increased, i.e., 77.52 and 70.60%, respectively. This matches our expectations. However, Table 6 shows that the precision rates are reduced more than the increase of the recall rates in some cases. The F-score of KeX-based integration strategy in M1 model is 3.31% worse than that of the baseline M0. This shows that KeX did not perform well in this test set, because it cannot recommend good candidates at the integration stage. Moreover, Table 5 shows that the F-scores of all YA and YA-C models are better than the corresponding models in Table 3 where only the filtering strategies are used. This indicates that Yapex performed better in this test corpus, so that we can enhance the performance by using both the filtering and integration strategies. On the other hand, the F-scores of YB and YB-C are worse than those of M0 in Table 3 . This shows that the set of terms suggested by human experts is too weak to improve the performance in the integration strategies. Nevertheless, the models in Table 6 still cannot compete with M32 in Table 3 . The reason may be that some heuristic rules used in Yapex are borrowed from KeX (such as the use of feature terms, e.g., protein, particle, and receptor) [11] , and added additional filtering strategies (e.g., filtering out names of chemical substances, bibliographical references, chemical formulas, etc.).
Integration evaluation of genes
We have shown the evaluation results using our integration strategies in the protein domain in Section 5.2. A similar scheme can be applied to the gene domain.
Here, we employ the integration strategies to enlarge the candidate sets, and the gene collocates mentioned in Section 3 to filter out the less likely gene candidates. The terms suggested by human experts are not as complete as the ones our automated method produced. This is demonstrated by the following two sentences.
The binding capacity and affinity of the glucocorticoid receptors were measured and compared to clinical data and the plasma cortisol concentrations. An over-representation of T2 in ovarian cancer patients compared with controls in the pooled Irish/German population (P<0.025) was observed.
The protein glucocorticoid receptors and gene T2 are collocated with ''compared'' which is missed by human experts.
Since the terms suggested by human experts are not as complete as the ones extracted from the corpus, we did not conduct experiments on the terms suggested by human experts in this section. In the following, two sets of experiments for different bases (i.e., ABGene and Idgene), called AB-and Id-based integration strategies, respectively, are conducted.
(1) AB and ID: In these experiments, we use the gene collocates automatically extracted in Section 3 to filter out the candidates merged from the results of ABGene and Idgene. (2) AB-C and ID-C: If ABGene and Idgene recommend the same gene names, we will select them without consideration of gene collocates. Otherwise, we will use the gene collocates proposed in this study to do the filtering.
The evaluation results of integration strategies on gene domain are listed in Tables 7 and 8 .
Some results are in agreement with those in the protein experiments. First, the tendencies M32 > M31 > M2 > M1 are still kept in the gene experiments. Second, the recall rates of all models in AB-based integration are increased compared with the recall rate of M0 in Table 4 . Third, the results AB-C > AB and ID-C > ID are similar to the results YA-C > YA and KA-C > KA. These results demonstrate that (1) the strategy of delaying the decision until clear evidence is found is useful, (2) the integration strategy is workable for collecting additional correct molecular entities, and (3) if two systems recommend the same biological name, it is an important cue. We now examine Tables 7 and 8 further. Table 7 shows that the precision rates are decreased less than the increase of the recall rates. In contrast, the precision rates are Table 7 Evaluation results on AB-based integration strategy Table 8 Evaluation results on Id-based integration strategy decreased more than the increase of the recall rates shown in Table 8 . Idgene-based strategies cannot compete with the M32 strategy in Table 4 . This means that the ABbased integration strategy performed well in this test set, but the Id-based integration strategy did not achieve a good performance. In other words, ABGene performed better in this test set than Idgene. Consequently, we infer that ABGene recommended more good candidates than Idgene. The reason may be that ABGene is a general-purpose gene recognizer [13] and Idgene focuses on Chinese Gene Variation [28] . Meanwhile, the test set, i.e., the GENIA corpus, covers general documents, rather than documents in some specific topic like Chinese Gene Variation. This leads to the decreased performance of Idgene, which is worse than ABGene. Table 9 summarizes the results of this paper. We propose a fully automatic method of mining collocates from scientific texts in the protein and gene domains, and employ the extracted collocates to improve the precision rate of protein/gene name recognition. The precision of Yapex is increased from 70.90 to 85.84% at a small expense in the recall rate (i.e., it only decreases 2.44%) when collocates are incorporated. When the integration-only approach is adopted (i.e., Àfiltering, +integra-tion), the F-score of the Yapex-based (ABGene-based) integration is a little lower than that of the filtering-only approach (i.e., +filtering, Àintegration). This shows that collocation learning is useful, and integration depends on the individual performance NE recognizers. When both filtering and integration (i.e., +filtering, +integra-tion) strategies are employed together, the Yapex-based integration with KeX achieves 7.83% F-score increase compared to the pure Yapex method (i.e., Àfiltering, Àintegration). The ABGene-based integration with Idgene shows a 10.18% F-score increase relative to the pure ABGene method.
Concluding remarks
The main benefits of our method are: (1) The collocates used in the filtering strategies are produced by the training corpus rather than by intuition. This forms a more complete set than one identified by human experts; (2) The combination of the filtering and integration strategies shows better performance than the original protein/gene name taggers. The main drawback of our method is that we cannot solve the problem of false negatives. To solve such problems, more linguistic technologies need to be investigated in order to recover the false negatives. In addition, the performance of integrity strategies relied on the performance of the selected taggers as shown in Table 9 .
This tendency is consistent with gene and protein name entity extraction. We expect that the methodologies can be easily extended to other domains, such as drugs and diseases. This will be verified in future work. The protein (or gene) collocates extracted from the domain corpus are also important keywords for pathway discovery, so that a systematic way from basic named entities finding to the discovery of complex relationships can be explored. Although the relation extraction involves more complex issues, such as related objects, pathway direction and dependency relation, the correct recognition of genome/protein is the most basic task and this can be help with our methods. The values of the frequency, average distance, standard deviation and t-score can serve as some features for machine learning approaches to tag the protein/gene names. This will be studied. The experimental systems adopted in this paper are rule-based. The effects of combining different types of protein/gene name taggers, e.g., rulebased and corpus-based, will be investigated in the future. 
